HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.

Abstract
Helicobacter pylori is a human class I carcinogen and no effective prophylactic or therapeutic H. pylori vaccine has yet been marketed. H. pylori can escape the host immune response, but the precise immune protection mechanisms in humans remain unknown. In this study, we developed a multivalent, subunit H. pylori vaccine candidate by formulating three commonly used H. pylori antigens, neutrophil-activating protein (NAP), urease subunit A (UreA) and subunit B (UreB) with the mucosal adjuvant, a double-mutant heat-labile toxin (dmLT) from Escherichia coli, and evaluated its immunogenicity and therapeutic efficacy in a mouse model of H. pylori infection. We found that oral immunization of H. pylori-infected mice significantly reduced gastric bacterial colonization at both 2 and 8 weeks after immunization. The reduction in bacterial burdens was accompanied with significantly increased serum antigen-specific IgG responses and mucosal IgA responses. Moreover, oral immunization also induced Th1/Th17 immune responses, which may play a synergistic role with the specific antibodies in the elimination of H. pylori. Thus, our vaccine candidate appears able to overcome the immune evasion mechanism of H. pylori, restore the suppression of Th2 immune responses with the induction of a strong humoral immune response. These results lay the foundation for the development of an optimized oral therapeutic H. pylori vaccine with increased immunogenicity of UreA and UreB, as well as providing long-term immunity.
AuthorsMeiying Liu, Youxiu Zhong, Jing Chen, Yu Liu, Chongfa Tang, Xuewei Wang, Yanbin Zhang, Ping Wang, Susan M Logan, Wangxue Chen, Bo Wei
JournalVaccine (Vaccine) Vol. 38 Issue 14 Pg. 3031-3041 (03 23 2020) ISSN: 1873-2518 [Electronic] Netherlands
PMID32139315 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCrown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Bacterial Vaccines
  • Immunoglobulin A
  • Immunoglobulin G
  • Vaccines, Combined
  • Vaccines, Subunit
  • Urease
Topics
  • Adjuvants, Immunologic
  • Administration, Oral
  • Animals
  • Antibodies, Bacterial (immunology)
  • Antigens, Bacterial (immunology)
  • Bacterial Vaccines (administration & dosage)
  • Helicobacter Infections (prevention & control)
  • Helicobacter pylori (immunology)
  • Immunization (methods)
  • Immunogenicity, Vaccine
  • Immunoglobulin A (immunology)
  • Immunoglobulin G (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Urease (immunology)
  • Vaccines, Combined (administration & dosage)
  • Vaccines, Subunit (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: